- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03688737
Low Level Laser in Isolated Cleft Palate Repair Versus Surgical Correction Without LLL in Healing Process
The Effect of Adjunctive Use of Low Level Laser (LLL) After Surgical Correction of Isolated Cleft Palate Versus Surgical Correction Without LLL in Healing Process
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Primary objective:
To evaluate the effect of adjunctive use of LLL after surgical correction of cleft palate in improving healing among children with cleft palate Secondary objectives To evaluate the effect of adjunctive use of LLL after surgical correction of cleft palate in decreasing incidence of oronasal fistula after surgical repair among children with cleft palate Study group: Will use LLL after surgical correction of cleft palate at day of surgery, 1st day and 3rd day Control group: Surgical correction of cleft palate without Adjunctive use of LLL
Inclusion criteria:
- Age: between 6 to 18 months of age
- Patient has isolated cleft palate
Exclusion criteria:
- Systemic disease
- Hematological disorder Outcome: Outcome measure (s) (1ry, 2ry) 1ry: healing assessment 2ry: occurrence of oronasal fistula
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: El noman MK El shafie, M.Sc.
- Phone Number: 002001063999203
- Email: nomanmust@yahoo.com
Study Contact Backup
- Name: Basma GM Moussa, Prof
- Phone Number: 002001005644098
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Age: between 6 to 18 months of age
- Patient has isolated cleft palate
Exclusion Criteria:
- Systemic disease
- Hematological disorder
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Placebo Comparator: control group
A) Control group: Has Surgical procedures "von Langenbeck technique " to repair cleft palate and will come for follow up visit at day of surgery, 1st day and 3rd day for placebo device like LLL and come for follow up visits at 5th day ,2 weeks, month and 3 months postoperative |
placebo like device as it like low level laser device shape but with no effect to blind the intervention
|
Active Comparator: study group
B) Study group: This group will be subjected to the same surgical procedure "von Langenbeck technique "to repair cleft palate but low level laser Therapy will be at day of surgery, 1st day and 3rd day and come for follow up visits at 5th day ,2 weeks, month and 3 months postoperative |
LLLT with wavelength (λ) of (600 nm to 700nm), The laser will be held 1 cm away from the surface of the target tissue, the irradiated area is 0,5 cm2.The area of impact is the surgical wound zone and the neighboring 0,5-1,0 cm of the adjacent oral mucosa for 1min and 22sec, at day of surgery, 1st day and 3rd day and come for follow up visits at 5th day ,2 weeks, month and 3 months postoperative
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
wound healing
Time Frame: 2 years
|
healing by days to closure
|
2 years
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
occurrence of oronasal fistula
Time Frame: 3 months
|
Postoperative complications; mainly oronasal fistula by; clinical observation: inspection, clinical signs: regurgitation of food or drink
|
3 months
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Anticipated)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 172162009
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cleft Palate Children
-
UMC UtrechtRadboud University Medical Center; Academisch Medisch Centrum - Universiteit... and other collaboratorsRecruitingCleft Lip and Palate | Cleft Palate Children | Cleft Alveolar RidgeNetherlands
-
AZ Sint-Jan AVCompletedCleft Palate ChildrenBelgium
-
Ann & Robert H Lurie Children's Hospital of ChicagoEnrolling by invitation
-
University GhentResearch Foundation FlandersNot yet recruitingCleft Lip and Palate | Cleft Palate Children | Speech Therapy | Speech Disorders in Children
-
University GhentResearch Foundation FlandersRecruitingCleft Lip and Palate | Cleft Palate Children | Speech Therapy | Speech Disorders in ChildrenBelgium
-
University Hospital, GhentUniversity GhentRecruiting
-
AZ Sint-Jan AVRecruiting
-
Assiut UniversityUnknownCleft Palate Children | BlockEgypt
-
Lagos State UniversityUniversity of Lagos, NigeriaRecruitingCleft Palate | Cleft Lip and Cleft Palate | Cleft Lip, Cleft Alveolus and Cleft PalateNigeria
-
Cairo UniversityRecruitingCleft Lip and Palate | Bilateral Cleft Lip/PalateEgypt
Clinical Trials on placebo
-
SamA Pharmaceutical Co., LtdUnknownAcute Bronchitis | Acute Upper Respiratory Tract InfectionKorea, Republic of
-
National Institute on Drug Abuse (NIDA)CompletedCannabis UseUnited States
-
AstraZenecaParexel; Spandauer Damm 130; 14050; Berlin, GermanyCompletedMale Subjects With Type II Diabetes (T2DM)Germany
-
Heptares Therapeutics LimitedCompletedPharmacokinetics | Safety IssuesUnited Kingdom
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited Kingdom, Netherlands
-
Shijiazhuang Yiling Pharmaceutical Co. LtdXuanwu Hospital, BeijingCompleted
-
ItalfarmacoCompletedBecker Muscular DystrophyNetherlands, Italy
-
GlaxoSmithKlineCompletedInfections, BacterialUnited States
-
West Penn Allegheny Health SystemCompletedAsthma | Allergic RhinitisUnited States